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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌto 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Summary Vision Screening Data: Switzerland                                                             
v 
 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation  
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3 Population and Healthcare Overview 
The population of Switzerland is 8,466,017 (World Bank, 2018a) and birth rate is estimated 
at 10.5 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Switzerland has a reported population density of 214 people per square kilometre in 2017 
and this has risen from 138 people per square kilometre in 1961 (World Bank, 2018c). Infant 
mortality in 2017 is estimated at 3.7 deaths/1,000 live births in total (World Bank, 2018d). 
The average life expectancy in Switzerland is estimated at 82.9 years (World Bank, 2018e), 
with a death rate of 7.8 deaths/1,000 population in 2016 (World Bank, 2018f). Switzerland 
has a gross national income per capita (PPP int. $, 2013) of $56,000 (WHO, 2016). The 
estimated total expenditure on health per capita in 2014 was $6,468 (Intl $) and the total 
expenditure on health in 2014 as percentage of GDP was 11.7% (WHO, 2016). 
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Figure 1: Change in the Total Population and Birth Rate in Switzerland between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
In Switzerland, vision screening is not embedded into a general preventative child healthcare 
screening system. It is organised regionally (Cantons) therefore differences exist between 
regions in relation to coverage, personnel delivering screening, tests used and funding. Vision 
screening is funded through either mandatory health insurance, the state or municipalities.  
The content of the vision screening programme is decided upon by those professionals 
involved in screening within each region. There is no consensus on this, most often an official 
physician, ( ?ĐĂŶƚŽŶĂů ĚŽĐƚŽƌ ?) decides on the procedure. However, the screening content 
itself is managed by the performing personnel.  
It is not known when vision screening began, or when it was implemented nationally. It is not 
known if the vision screening programme has been changed since its start date and there are 
no guidelines or general regulations for vision screening. If there are any revisions to a 
programme, this is decided upon on a regional basis with no regulations pertaining to how 
revisions take place or the funding of this work.  
In Switzerland, paediatricians, midwives, nurses, specialist nurses, ophthalmologists, 
orthoptists and general practitioners (GP) conduct vision screening. It is not known how many 
of these professionals there are, per million population. No other general healthcare 
professionals have been identified that could deliver vision screening with additional training. 
Currently there is no specific training to perform vision screening, healthcare professionals 
gain this knowledge from their general training. 
There are no methods for quality monitoring imposed by the government and no information 
is collected. There has been research carried out concerning the effectiveness of a vision 
screening programme in Switzerland (Eppenberger et al., 2016) which assessed the current 
local situation in the canton of St. Gallen and found that there was variation between 
locations. No research concerning the cost-effectiveness.  
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5 Screening programme  
In Switzerland, the target conditions screened for include retinopathy of prematurity (ROP), 
congenital eye disorders, amblyopia, reduced visual acuity, refractive error, colour vision 
defects and strabismus. The health care professionals delivering vision screening, venue for 
screening and tests used vary depending on the age of the child as shown in Tables 1, 2 and 
3 respectively. Specific details of the screening offered within each age group are described 
more fully in sections 5.1 to 5.4 below. It is also important to note that there is no consensus 
and therefore vision screening procedures vary depending on regions and/or professional 
screening. The information available and given below is generally indicative of Switzerland, 
but relates specifically to the Canton of St. Gallen. 
5.1 Vision screening - Preterm babies 
Preterm babies, up to the age of 3 months, are screened by an ophthalmologist in a 
neonatology department of a hospital. Preterm babies are determined as < 32 weeks 
ŐĞƐƚĂƚŝŽŶĂů ĂŐĞ ĂŶĚ ?Žƌ A?  ? ? ? ? ŐƌĂŵƐ ? Žƌ ǁŝƚŚ ŽǆǇŐĞŶ ƐƵƉƉůĞŵĞŶƚĂƚŝŽŶ A?  ? ĚĂǇƐ ?
Ophthalmoscopy (slit lamp examination if necessary) is performed according to the 
international guidelines. Otherwise, light reflex test is performed in the first week, month 1 
and month 2 according to the guidelines of the Swiss Society of Paediatrics. The vision 
screening tests utilised include eye inspection, fixation and retinal examination; this is 
dependent upon age and weight.   
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by either a paediatrician, 
midwife, specialist nurse, ophthalmologist or orthoptist. The vision screening tests 
administered at this age include eye inspection, fixation, retinal examination and pupillary 
reflexes. The screening is performed in the first week, month 1 and month 2. These tests are 
conducted in either a hospital, child healthcare centre, or a private clinic. Criteria that 
necessitate referral to an ophthalmologist for further diagnostic examination include any eye 
abnormality (e.g. leukocoria etc.). There are no consensus guidelines for referral, it is at the 
discretion of the examiner. Vision screening is not repeated, before referral for further 
diagnostic examination, children are referred immediately if they do not pass the screening 
procedure.   
5.3 Vision screening - 3 months to 36 months 
Infants aged from 3 to 36 months are screened by either a paediatrician, specialist nurse, 
ophthalmologist, orthoptist, optometrist/optician, or GP. The vision screening tests 
administered at this age include eye inspection, fixation, red reflex testing, eye motility, 
Hirschberg test, pursuit movements, pupillary reflexes, cover test, alternating cover test, 
visual acuity measurement, stereopsis (no consensus, most often Lang I and II, Titmus) and 
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colour vision (no concensus, most often Ishihara). Autorefraction (Retinomax Autorefractor) 
and automated screening (PlusOptix) are sometimes performed, but this depends on the 
examiner. These tests are conducted in either a hospital, child healthcare centre, 
kindergarten, school, private clinic, or public place.  
Visual acuity (VA) is measured for the first time at age 2.5 years and the optotype charts used 
include Cardiff Acuity Cards, Lea symbols, Snellen, Tumbling E, Landolt C and Numbers. For 
each chart it is variable in terms of whether they are logMAR, linear, crowded or uncrowded 
charts, the range of optotype sizes used, or if different visual acuity charts are used for 
different ages and how this differs between regions. This is due to the fact that there is no 
consensus and it is dependent upon the preferences of the examiner. It is dependent upon 
the examiner as to when visual acuity is measured again and there is no consensus for this. 
VA is measured by either a paediatrician, specialist nurse, ophthalmologist, orthoptist, 
optometrist/optician, or a GP. Criteria that necessitate referral to an ophthalmologist for 
further diagnostic examination include VA of equal to or less than 0.8 decimal (0.1 logMAR, 
6/7.5 Snellen), 1 or 2 lines difference in visual acuity, lacking stereovision, or any other eye 
abnormality (e.g. leukocoria). This is true for large cities including Zurich, however it depends 
on the individual screening as there are no consensus guidelines. Vision screening is not 
repeated, before referral for further diagnostic examination, children are referred 
immediately if they do not pass the screening procedure.   
5.4 Vision screening - 36 months to 7 years 
Children aged between 36 months and 7 years receive vision screening delivered by either a 
paediatrician, specialist nurse, ophthalmologist, orthoptist or a GP in hospitals, child 
healthcare centres, kindergarten, schools, private clinics, or public places. The vision 
screening tests administered at this age include eye inspection, fixation, red reflex testing, 
eye motility, Hirschberg test, pursuit movements, pupillary reflexes, cover test, alternating 
cover test, visual acuity measurement, stereopsis (no consensus, most often Lang I and II, 
Titmus) and colour vision (no concensus, most often Ishihara). Autorefraction (Retinomax 
Autorefractor) and automated screening (PlusOptix) are sometimes performed, but this 
depends on the examiner.  
 
The optotype charts used include Cardiff Acuity Cards, Lea symbols, Snellen, Tumbling E, 
Landolt C and Numbers. Criteria that necessitate referral to an ophthalmologist for further 
diagnostic examination include a VA of equal to or less than 0.8 decimal (0.1 logMAR, 6/7.5 
Snellen) 1 or 2 lines difference in VA, lacking stereovision, or any other eye abnormality (e.g. 
leukocoria etc.). This is true for large cities including Zurich, however it depends on the 
individual screening as there are no consensus guidelines. Vision screening is not repeated, 
before referral for further diagnostic examination, children are referred immediately if they 
do not pass the screening procedure.    
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Paediatrician Midwife Specialist 
Nurse 
Ophthalmologist Orthoptist Optometrist GP 
Preterm babies  × × × 9 × × × 
0 to 3 months  9 9 9 9 9 × × 
3 to 36 months  9 × 9 9 9 9 9 
3 to 7 years  9 × 9 9 9 × 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 EI Fix RE PR RR EM Hir PM CT ACT VA SV CV AR AS 
Preterm 
babies  9 9 9 × × × × × × × × × × × × 
0 to 3 
months  9 9 9 9 × × × × × × × × × × × 
3 to 36 
months  9 9 × × 9 9 9 9 9 9 9 9 9 9 9 
3 to 7 
years  9 9 × × 9 9 9 9 9 9 9 9 9 9 9 
Key: EI: Eye Inspection; Fix: Fixation; RR: Red Reflex Testing; EM: Eye Motility; Hir: Hirschberg test; RE: Retinal Examination; PM: Pursuit Movements; PR: 
Pupillary Reflexes; CT: Cover Test; ACT: Alternating Cover Test; VA: Visual Acuity; SV: Stereopsis; CV: Colour Vision; AR: Autorefraction; AS: Automated Screening 
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Table 3: Location of vision screening for each age group  
Table 3 
Hospital Child Healthcare 
Centre 
Kindergarten Private Clinic School Public Place 
Preterm babies  9 × × × × × 
0 to 3 months  9 9 × 9 × × 
3 to 36 months  9 9 9 9 9 9 
3 to 7 years  9 9 9 9 9 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia that focus on detection of the actual condition and the resulting visual loss.  
In Switzerland, the automated screening devices used are PlusOPtix and Retinomax 
autorefractor. Automated screening is only rarely performed, it depends on individual 
preferences of the examiner. Therefore, there is no information concerning:  
x The ages at which these are performed 
x If other tests are used too 
x If all children, or just a select group of borderline/fails are tested with these 
x If there is comparative data between regions that do and do not conduct these tests 
x What the referral criteria are 
The cost of these devices, the maintenance costs per year and after how many years a device 
is scheduled for replacement are not known. 
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7 Provision for Visually Impaired  
In Switzerland, there are 25 schools for blind or severely visually impaired children. The costs 
per child for these schools is not known. There is additional support for visually impaired 
children who attend regular mainstream primary school, in the way of vision aids such as 
magnifying glasses and special glasses. This differs between regions.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia by the age of 7 years is estimated to be 2-
4% using the criteria of 2 or more lines difference in VA between the eyes. The prevalence of 
persistent amblyopia (missed by screening or failed treatment) by the age of 7 years (N= 
7,499) is 2% (Sturm et al., 2016). The prevalence of strabismus is 2-4% in preschool children 
(Sturm et al., 2016). The incidence (observed cases) of the four types of amblyopia (strabismic, 
refractive, combined mechanism and deprivation) is not known.  
8.2 Coverage 
The percentage of children invited for vision screening is not known, and it is not known who 
invites children for general preventative child healthcare screening, or how this is conducted. 
The coverage of vision screening, before the age of 7 years is not known. The attendance rate 
of vision screening, before the age of 7 years is 80-90%, this is also true for the coverage of 
VA measurements as part of vision screening (Sturm et al., 2016). The percentage of 
compliance with referral after an abnormal screening test result is not known and it is unclear 
if there is registration or documentation of noncompliance with referral after an abnormal 
screening test result. 
8.3 Screening evaluation 
The percentage of false negatives for vision screening, after the screening is completed is 
estimated at less than 10%. The percentage of false positives for vision screening is estimated 
at less than 10%. The positive predictive value of a refer result after vision screening is not 
known. The sensitivity and specificity of vision screening is not known.  
8.4 Treatment success 
The estimated percentage of infants treated for congenital eye disorders in the total 
population is 0.1%. The estimated percentage of children treated for strabismus, after being 
screened before the age of 7 years is 2-3%. The estimated percentage of children treated for 
strabismus is also 2-3%. The estimated percentage of children treated for amblyopia, after 
being screened before the age of 7 years is estimated at 2-3%; this rises to 4% of all children 
treated for amblyopia before the age of 7 years. The number of patients treated for congenital 
cataract, amblyopia and strabismus, per year by orthoptists and/or ophthalmologists is 
40,000 in Switzerland. Ophthalmologists and orthoptists are the only professionals that 
prescribe glasses for children under the age of 7 years. Other treatment options include 
patching, penalisation with glasses, atropine, strabismus surgery and cataract surgery. All 
eligible children are treated.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The actual salary costs per year for vision screening professionals is not known. However, the 
salary costs per hour for vision screening professional ranges from 50-150 CHF (44 to 131 
Euros in October 2018). It is not known how much it costs to train general preventative child 
healthcare screening professionals between leaving secondary education to qualification. It 
is not known what the total screening costs, per year, for vision screening is in Switzerland. 
The total costs per child are also unknown.  
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients with refractive amblyopia and strabismic 
amblyopia, including follow up, are not known.  
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery, including follow up, are not known.  
9.4 Cost of treatment for cataract 
The estimated cost for congenital cataract surgery, including follow up of deprivation 
amblyopia, are not known.  
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